about
Strategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosisEndophytic fungi: a reservoir of antibacterialsSimultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivoEvaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expressionCharacteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experienceMycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages.Virtual Screening of potential drug-like inhibitors against Lysine/DAP pathway of Mycobacterium tuberculosisMutations in extensively drug-resistant Mycobacterium tuberculosis that do not code for known drug-resistance mechanisms.Synthesis and biological evaluation of aminonaphthols incorporated indole derivatives.Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.Mycobacterium tuberculosis Complex Genotype Diversity and Drug Resistance Profiles in a Pediatric Population in Mexico.Polyphosphate deficiency in Mycobacterium tuberculosis is associated with enhanced drug susceptibility and impaired growth in guinea pigs.Mycobacterium tuberculosis: drug resistance and future perspectives.Productive steps toward an antimicrobial targeting virulence.Triazole: A Promising Antitubercular Agent.Nucleoside analogs and tuberculosis: new weapons against an old enemy.Controversies and unresolved issues in tuberculosis prevention and control: a low-burden-country perspective.Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.Inhalation of recombinant adenovirus expressing granulysin protects mice infected with Mycobacterium tuberculosis.Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolatesUntreated depression and tuberculosis treatment outcomes, quality of life and disability, Ethiopia.
P2860
Q27003186-94A5A15D-5E14-4C1F-9FBE-424865325398Q28083549-28F341B8-434A-4F32-9FD9-91CDBB8190CDQ28476622-CEB1643C-EAD3-400E-8307-3AD408171043Q28477282-7AB7D40A-F3A5-481D-AAE0-FE228825BC4DQ28478005-66479874-9521-4FDC-BD27-07DB5A79F341Q33526364-4B71135B-31CC-4F78-BA2F-BC22B575E589Q33528248-2D8B40A9-9F8F-41CC-8B3A-C28D4C1DEB98Q33678559-A89CFB5E-09D5-4C34-9F20-048148AF13D0Q34393465-C90F082C-0882-4523-98E6-E17B7739282AQ35067024-D4D225FF-DDF2-4F73-84DB-0ABA827CCC33Q35910338-76CE720E-A0E1-420E-9FC1-DA1CEE4CA466Q36969514-B0E9402D-DDD5-483D-BE90-A7DE4A149E3AQ37506524-5C153546-5363-400C-AC0E-E00D9325554BQ37561914-D4AFE803-C976-42D3-B314-77498A5E35C3Q38341275-69FEDDFB-EAAF-4746-BCBD-83A56F264486Q38397331-685D9610-C302-4E9D-A3A4-003BB9564563Q39636742-F926041E-67D6-43FC-B0A7-185C63260F70Q39786340-28DEC44C-4080-4025-9596-EBE8C51CDBEFQ41105185-ADEEFF71-80F0-48AB-88FB-70FFDA70EC54Q42773182-EC0AC195-A7E9-49E8-9309-C8AABDB6C111Q53689321-D82CE6FE-9C25-4FDB-8A1B-0DC1FC689B8D
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Extensively drug-resistant tuberculosis
@ast
Extensively drug-resistant tuberculosis
@en
Extensively drug-resistant tuberculosis
@nl
type
label
Extensively drug-resistant tuberculosis
@ast
Extensively drug-resistant tuberculosis
@en
Extensively drug-resistant tuberculosis
@nl
prefLabel
Extensively drug-resistant tuberculosis
@ast
Extensively drug-resistant tuberculosis
@en
Extensively drug-resistant tuberculosis
@nl
P1476
Extensively drug-resistant tuberculosis
@en
P2093
Philip LoBue
P304
P356
10.1097/QCO.0B013E3283229FAB
P407
P577
2009-04-01T00:00:00Z